This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| ARM Holdings | Jefferies ups to Buy from Hold, ups TP to 1300p from 805p |
| Betfair Group | Nomura downgrades to neutral from Buy; TP to 766p from 890p |
| Booker | UBS ups TP to 141p from 127p, Buy |
| Hikma Pharmaceuticals | Jefferies ups TP to 1150p from 900p, Buy |
| Home Retail | SocGen ups TP to 158p from 152p, Hold |
| Home Retail | Nomura ups to neutral from reduce; TP to 148p from 93p |
| Homeserve | Jefferies ups to Buy from Hold; TP to 250p from 225p |
| Inchcape | UBS downgrades to neutral from Buy * UBS ups TP to 550p from 540p |
| International Consolidated Airlines | Morgan Stanley ups to overweight from equal-weight |
| International Consolidated Airlines | Morgan Stanley adds to Europe best ideas |
| International Personal Finance | RBC ups to outperform from sector perform |
| International Personal Finance | RBC ups TP to 540p from 360p |
| Petropavlovsk | Citigroup cuts TP to 274p from 377p, neutral |
| Provident Financial | RBC downgrades to sector perform from outperform |
| Provident Financial | RBC ups TP to 1700p from 1600p |
| Regus | Jefferies ups TP to 200p from 130p, Buy |
| Smiths Group | SocGen ups TP to 1175p from 940p, sell |
| The Paragon Group of Companies | RBC ups TP to 370p from 300p, sector perform |
| WPP | UBS ups TP to 1,080p from 875p, neutral |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research